Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDIV × Warts × Clear all

Phase

Status

Sponsor Class

OTHER 12 INDUSTRY 2 INDIV 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Neoplasms 2 Myasthenia Gravis 2 Warts 1 Vaginosis, Bacterial 1 Uterine Cervical Neoplasms 1 Syphilis 1 Sexually Transmitted Diseases 1 Pilonidal Sinus 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Herpes Genitalis 1 HIV Infections 1 Gonorrhea 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Chlamydia Infections 1 Barrett Esophagus 1 Anemia 1

Interventions

ethyl pyruvate 1 compound W 1 Salicylates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01712295 2012-10-23

17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts

Grossman, Michael, D.P.M.

Phase 4 Unknown

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡